Internal Medicine, Gastroenterology · San Antonio, TX
NPI
1871672519
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8550 Datapoint Dr, Suite 200
San Antonio, TX, 78229
Phone (210) 615-8308
Groups this clinician bills Medicare through
Medicare paid, 2024
$234K
9,891 services
Medicare patients, 2024
602
Average age 74
Drug cost, 2024
$625K
1,221 prescriptions
Company payments, 2025
$1,676
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Russell D Havranek was code 88305 (surgical pathology examination), 930 times for 268 patients. In total Russell D Havranek billed 9,891 services in 46 codes, and Medicare paid $234K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 930 | 268 | $25.22 | $23K |
| 99213 Office E&M - Established | Office | 237 | 175 | $63.49 | $15K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 196 | 29 | $36.50 | $7,155 |
| 99443 Telephone Services | Office | 189 | 139 | $69.46 | $13K |
| 43239 Upper GI Endoscopy | Facility | 170 | 162 | $61.32 | $10K |
| 88342 Immunohistochemistry | Office | 151 | 137 | $53.18 | $8,029 |
| 45380 Lower GI Endoscopy - Other | Facility | 147 | 147 | $116.63 | $17K |
| 88313 Surgical Pathology Examination | Office | 123 | 90 | $52.22 | $6,423 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 111 | 29 | $47.77 | $5,302 |
| 88341 Immunohistochemistry | Office | 104 | 69 | $47.02 | $4,890 |
| 99214 Office E&M - Established | Office | 82 | 77 | $84.16 | $6,901 |
| 91065 Test - Miscellaneous | Office | 80 | 37 | $51.61 | $4,129 |
| 99203 Office E&M - New | Office | 69 | 69 | $78.84 | $5,440 |
| 45378 Lower GI Endoscopy - Other | Facility | 58 | 58 | $118.44 | $6,870 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 38 | 38 | $173.04 | $6,576 |
By year: 2022 $297K for 10,230 services; 2023 $243K for 10,764 services; 2024 $234K for 9,891 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 930 | 268 | $25.22 | $23K |
| 88342 Immunohistochemistry | 151 | 137 | $53.18 | $8,029 |
| 88313 Surgical Pathology Examination | 123 | 90 | $52.22 | $6,423 |
| 88341 Immunohistochemistry | 104 | 69 | $47.02 | $4,890 |
Medicare prescription drug claims, 2024
In 2024, the drug Russell D Havranek prescribed most often to Medicare patients was Omeprazole, with 245 prescriptions and refills. In total Russell D Havranek wrote 1,221 Medicare prescriptions that cost $625K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 245 | 502 | 67 | $2,802 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 202 | 202 | 202 | $12K |
| Pantoprazole Sodium Generic | 126 | 264 | 36 | $1,935 |
| Famotidine Generic | 54 | 118 | 16 | $791 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 48 | 54 | 19 | $1,484 |
| Dicyclomine Hcl Generic | 47 | 68 | 14 | $998 |
| Dexlansoprazole Dr Dexlansoprazole | 32 | 46 | Under 11 | $7,497 |
| Sucralfate Generic | 31 | 60 | Under 11 | $665 |
| Ondansetron Odt Ondansetron | 30 | 32 | Under 11 | $720 |
| Metoclopramide Hcl Generic | 27 | 27 | Under 11 | $172 |
| Linzess Linaclotide | 24 | 28 | Under 11 | $15K |
| Cholestyramine Cholestyramine (With Sugar) | 22 | 31 | Under 11 | $896 |
| Budesonide Dr Budesonide | 21 | 27 | Under 11 | $6,671 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 20 | 20 | 20 | $311 |
| Lubiprostone Generic | 18 | 30 | Under 11 | $2,363 |
Brand drugs: 264 claims; generic drugs: 957 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Russell D Havranek $1,676 ($1,676 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $402.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $402 |
| Genzyme Corporation SNY | 6 | $246 |
| Janssen Biotech, Inc. JNJ | 12 | $222 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $124 |
| Celltrion USA Inc. 068270.KS | 5 | $121 |
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $99.07 |
| Lilly USA, LLC LLY | 4 | $78.36 |
| QOL Medical, LLC | 3 | $71.5 |
| Aimmune Therapeutics, Inc. | 4 | $66.35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $64.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.